Phase II Trial Opens: Guanfacine Extended Release vs Placebo in Alcohol Use Disorder — Telehealth-Based Approach Shows Promise
247 Health News Editorial
·19 May 2026
·3 min read
·clinical-trialsA new phase II trial is testing guanfacine extended release against placebo for alcohol use disorder using telehealth delivery. The study targets stress-related drinking patterns and could expand treatment options for AUD.
Originally reported by ClinicalTrials.gov
References
- 1.Arnaud, N., Baldus, C., Elgan, T. H., et al. (2020). Effectiveness of a web-based screening and brief intervention for alcohol use in general hospital patients: study protocol for a pragmatic randomized controlled trial. Trials, 21, 639. https://doi.org/10.1186/s13063-020-04648-8
- 2.Australian Institute of Health and Welfare. (2023). Alcohol, tobacco & other drugs in Australia. AIHW. https://www.aihw.gov.au/reports/alcohol/alcohol-tobacco-other-drugs-australia
- 3.Fox, H. C., Bergquist, K. L., Hong, K. I., & Sinha, R. (2007). Stress-induced and alcohol cue-induced craving in recently abstinent alcohol-dependent individuals. Alcoholism: Clinical and Experimental Research, 31(3), 395-403. https://doi.org/10.1111/j.1530-0277.2007.00395.x
- 4.Indiana University. (2024). Guanfacine for Alcohol Use Disorder (AUD): a Telehealth Approach. ClinicalTrials.gov. NCT06629259. https://clinicaltrials.gov/study/NCT06629259
- 5.Jonas, D. E., Amick, H. R., Feltner, C., et al. (2014). Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA, 311(18), 1889-1900. https://doi.org/10.1001/jama.2014.3628
- 6.Koob, G. F., & Volkow, N. D. (2016). Neurobiology of addiction: a neurocircuitry analysis. The Lancet Psychiatry, 3(8), 760-773. https://doi.org/10.1016/S2215-0366(16)00104-8
- 7.Lubman, D. I., Manning, V., Best, D., et al. (2014). A study of patient pathways in alcohol and other drug treatment. Medical Journal of Australia, 200(4), 214-218. https://doi.org/10.5694/mja13.11718
- 8.Riper, H., Hoogendoorn, A., Cuijpers, P., et al. (2018). Effectiveness and treatment moderators of internet interventions for adult problem drinking: an individual patient data meta-analysis of 19 randomised controlled trials. PLoS Medicine, 15(12), e1002714. https://doi.org/10.1371/journal.pmed.1002714
- 9.Simpson, T. L., Saxon, A. J., Meredith, C. W., et al. (2009). A pilot trial of the alpha-1 adrenergic antagonist, prazosin, for alcohol dependence. Alcoholism: Clinical and Experimental Research, 33(2), 269-275. https://doi.org/10.1111/j.1530-0277.2008.00807.x
2
247 Health News Editorial
247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.
Related Articles
clinical-trials
Digital Health Platform vs Case Manager Support in Hypertension Management: Taiwan's 1,726-Participant Trial Signals a Shift in Blood Pressure Care Delivery
3 Aug 2026
clinical-trials
Phase II Trial: AI-Powered Wysa Chatbot vs Unmet Need — Digital Eating Disorder Prevention in At-Risk Adolescents
3 Aug 2026
clinical-trials
Pilot Trial Targets the Inpatient-to-Outpatient Gap: Digital Smoking Cessation Intervention for Persons With Serious Mental Illness — Key Findings for Clinicians
3 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service